期刊
BIOCHEMICAL SOCIETY TRANSACTIONS
卷 44, 期 -, 页码 1441-1454出版社
PORTLAND PRESS LTD
DOI: 10.1042/BST20160065
关键词
-
资金
- National Institutes of Health/National Cancer Institute [F30CA196162, T32-GM007171, R01-CA135006, R01-CA136786]
Transforming growth factor-beta (TGF-beta) mediates numerous biological processes, including embryonic development and the maintenance of cellular homeostasis in a context-dependent manner. Consistent with its central role in maintaining cellular homeostasis, inhibition of TGF-beta signaling results in disruption of normal homeostatic processes and subsequent carcinogenesis, defining the TGF-beta signaling pathway as a tumor suppressor. However, once carcinogenesis is initiated, the TGF-beta signaling pathway promotes cancer progression. This dichotomous function of the TGF-beta signaling pathway is mediated through altering effects on both the cancer cells, by inducing apoptosis and inhibiting proliferation, and the tumor microenvironment, by promoting angiogenesis and inhibiting immunosurveillance. Current studies support inhibition of TGF-beta signaling either alone, or in conjunction with anti-angiogenic therapy or immunotherapy as a promising strategy for the treatment of human cancers.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据